First Time Loading...

Homology Medicines Inc
NASDAQ:FIXX

Watchlist Manager
Homology Medicines Inc Logo
Homology Medicines Inc
NASDAQ:FIXX
Watchlist
Price: 0.9347 USD 1 714.95% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

FIXX Price Targets Summary
Homology Medicines Inc

Wall Street analysts forecast FIXX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FIXX is 1.5 USD .

FIXX Lowest Forecast
Wall Street Target
Not Available
FIXX Average Forecast
Wall Street Target
1.5 USD
60% Upside
FIXX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
1.5 USD
60% Upside
Highest
Price Target
Not Available
Homology Medicines Inc Competitors:
Price Targets
L
2157
Lepu Biopharma Co Ltd
29% Downside
PBYI
Puma Biotechnology Inc
7% Downside
300439
MedicalSystem Biotechnology Co Ltd
124% Upside
DBV
DBV Technologies SA
216% Upside
L
2157
Lepu Biopharma Co Ltd
29% Downside
PBYI
Puma Biotechnology Inc
7% Downside
300439
MedicalSystem Biotechnology Co Ltd
124% Upside
DBV
DBV Technologies SA
216% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
ARGX
argenx SE
25% Upside
BIOCON
Biocon Ltd
2% Downside
KRTX
Karuna Therapeutics Inc
2% Downside

Revenue
Forecast

Revenue Estimate
Homology Medicines Inc

The compound annual growth rate of Homology Medicines Inc's revenue for the next 2 years is 32%.

N/A
Past Growth
32%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Homology Medicines Inc

Operating Income forecast
is not available for
Homology Medicines Inc

Net Income
Forecast

Net Income Estimate
Homology Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
FIXX intrinsic value, competitors valuation, and company profile.
DCF Valuation
FIXX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FIXX stock valuation using valuation multiples.
Wall Street Estimates
FIXX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FIXX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FIXX's stock price target?
Price Target
1.5 USD

According to Wall Street analysts, the average 1-year price target for FIXX is 1.5 USD .

What is Homology Medicines Inc's Revenue forecast?
Projected CAGR
32%

The compound annual growth rate of Homology Medicines Inc's revenue for the next 2 years is 32%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.